Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Trientine (Exclusively Dosage Form Fta), Atc A16Ax12 For The Period 05/01/26-04/30/28